Development Level
Tbio | 241 | 11,445 | |
Tclin | 39 | 613 | |
Tchem | 32 | 1,598 | |
Tdark | 5 | 6,588 |
Collection
GPCR: IDG Consortium (Targets) | 1 | 126 | |
RFA-RM-18-021 | 1 | 328 |
IMPC Phenotype
preweaning lethality, complete... | 33 | 979 | |
abnormal behavior | 14 | 298 | |
embryonic lethality prior to o... | 13 | 239 | |
hyperactivity | 10 | 148 | |
embryonic lethality prior to t... | 9 | 278 | |
enlarged heart | 8 | 210 | |
preweaning lethality, incomple... | 8 | 499 | |
decreased body weight | 7 | 161 | |
hypoactivity | 7 | 132 | |
decreased total body fat amoun... | 6 | 207 | |
decreased vertical activity | 6 | 208 | |
abnormal heart morphology | 5 | 162 | |
increased bone mineral density | 5 | 72 | |
limb grasping | 5 | 41 | |
abnormal embryo size | 4 | 220 | |
decreased circulating triglyce... | 4 | 79 | |
enlarged lymph nodes | 4 | 37 | |
hydrometra | 4 | 53 | |
increased circulating alkaline... | 4 | 122 | |
increased heart weight | 4 | 62 | |
increased lean body mass | 4 | 172 | |
increased mean corpuscular hem... | 4 | 96 | |
male infertility | 4 | 123 | |
abnormal behavioral response t... | 3 | 66 | |
abnormal coat-hair pigmentatio... | 3 | 64 | |
abnormal sleep behavior | 3 | 70 | |
decreased body length | 3 | 101 | |
decreased circulating choleste... | 3 | 93 | |
decreased circulating glucose ... | 3 | 126 | |
decreased circulating insulin ... | 3 | 76 | |
decreased circulating serum al... | 3 | 82 | |
enlarged spleen | 3 | 41 | |
impaired glucose tolerance | 3 | 75 | |
increased blood urea nitrogen ... | 3 | 48 | |
increased fasted circulating g... | 3 | 76 | |
increased monocyte cell number | 3 | 63 | |
increased total body fat amoun... | 3 | 134 | |
small superior vagus ganglion | 3 | 74 | |
abnormal bone structure | 2 | 187 | |
abnormal cornea morphology | 2 | 31 | |
abnormal epididymis morphology | 2 | 42 | |
abnormal eye morphology | 2 | 68 | |
abnormal gait | 2 | 69 | |
abnormal kidney morphology | 2 | 65 | |
abnormal seminal vesicle morph... | 2 | 114 | |
abnormal skin morphology | 2 | 50 | |
decreased bone mineral density | 2 | 126 | |
decreased circulating HDL chol... | 2 | 68 | |
decreased circulating alanine ... | 2 | 47 | |
decreased circulating aspartat... | 2 | 34 | |
decreased circulating calcium ... | 2 | 36 | |
decreased circulating fructosa... | 2 | 30 | |
decreased circulating total pr... | 2 | 49 | |
decreased eosinophil cell numb... | 2 | 24 | |
decreased grip strength | 2 | 116 | |
decreased heart weight | 2 | 27 | |
decreased lean body mass | 2 | 135 | |
decreased leukocyte cell numbe... | 2 | 73 | |
decreased lymphocyte cell numb... | 2 | 83 | |
decreased startle reflex | 2 | 75 | |
embryonic growth retardation | 2 | 106 | |
enlarged uterus | 2 | 11 | |
impaired pupillary reflex | 2 | 26 | |
improved glucose tolerance | 2 | 79 | |
increased bone mineral content | 2 | 108 | |
increased circulating calcium ... | 2 | 34 | |
increased circulating phosphat... | 2 | 26 | |
increased mean corpuscular vol... | 2 | 92 | |
increased or absent threshold ... | 2 | 101 | |
increased prepulse inhibition | 2 | 32 | |
increased startle reflex | 2 | 112 | |
microphthalmia | 2 | 26 | |
prenatal lethality prior to he... | 2 | 87 | |
prolonged PR interval | 2 | 15 | |
small testis | 2 | 58 | |
abnormal craniofacial morpholo... | 1 | 33 | |
abnormal lung morphology | 1 | 26 | |
abnormal retina morphology | 1 | 71 | |
abnormal retinal vasculature m... | 1 | 27 | |
abnormal spleen morphology | 1 | 55 | |
abnormal vibrissa morphology | 1 | 25 | |
abnormal whole-body plethysmog... | 1 | 4 | |
convulsive seizures | 1 | 13 | |
decreased caudal vertebrae num... | 1 | 53 | |
decreased circulating amylase ... | 1 | 28 | |
decreased circulating creatine... | 1 | 4 | |
decreased circulating iron lev... | 1 | 32 | |
decreased neutrophil cell numb... | 1 | 42 | |
increased blood uric acid leve... | 1 | 5 | |
increased body length | 1 | 32 | |
increased body weight | 1 | 25 | |
increased cardiac muscle contr... | 1 | 8 | |
increased circulating amylase ... | 1 | 25 | |
increased circulating aspartat... | 1 | 15 | |
increased circulating choleste... | 1 | 66 | |
increased circulating creatine... | 1 | 5 | |
increased circulating fructosa... | 1 | 13 | |
increased circulating potassiu... | 1 | 29 | |
prenatal lethality | 1 | 28 | |
vertebral fusion | 1 | 23 |
Disease
Tissue
Endocrine System | 312 | 18,159 | |
Digestive Tract | 305 | 17,369 | |
Female tissues | 304 | 17,400 | |
Nervous System | 303 | 16,725 | |
Skin and soft tissues | 303 | 17,230 | |
Male tissues | 301 | 17,142 | |
Blood and immune system | 296 | 16,909 | |
Liver and Pancreas | 295 | 16,750 | |
Urinary Tract | 294 | 16,678 | |
Respiratory system | 291 | 16,393 | |
Cardiovascular System | 270 | 15,192 |
Target Family
Non-IDG | 137 | 12,091 | |
Enzyme | 105 | 4,145 | |
Transcription Factor | 21 | 1,400 | |
Kinase | 15 | 634 | |
Ion Channel | 12 | 344 | |
Transporter | 12 | 473 | |
GPCR | 8 | 408 | |
Epigenetic | 4 | 242 | |
Nuclear Receptor | 2 | 48 | |
TF/Epigenetic | 1 | 38 |
This is where graphics are reside..